Copenhagen, Denmark; May 6, 2008 – Genmab A/S (OMX: GEN) announced today its management will attend two investor conferences in May 2008.  Professor Jan van de Winkel, President, Research & Development & Chief Scientific Officer and Chief Operating Officer, Claus Møller will attend the Merrill Lynch Pan European Biotech and Medical Devices One-on-One Forum in London, UK on May 15.  Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab, will present at the 2008 Citi Investment Research Global Health Care Conference in New York, NY, USA on May 21 at 11:30AM EDT. Dr. Drakeman’s presentation will be available via live and archived webcast at www.genmab.com.